Plunkett Research Online: Agenus Inc

AGENUS INC (AGEN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Agenus, Inc. is a biotechnology company that develops technologies and products to treat cancers and infectious diseases, primarily based on immunological approaches. The company’s most advanced product candidate is the Prophage series of cancer vaccines, a personalized series of therapeutic candid.....



Agenus Inc
Ticker: AGEN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 674-4400
Fax: 781 674-4200
Address: 3 Forbes Road
Lexington, MA 02421 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Cancers & Infectious Diseases Products & Technologies
ContactsDescription
Garo ArmenCEO/Chairman of the Board/Director/Founder
Christine KlaskinChief Accounting Officer/CFO/Vice President, Divisional
See More
Agenus, Inc. is a biotechnology company that develops technologies and products to treat cancers and infectious diseases, primarily based on immunological approaches. The company’s most advanced product candidate is the Prophage series of cancer vaccines, a personalized series of therapeutic candid.....See More See More

Auditor: KPMG LLP
Legal Advisor: Choate, Hall & Stewart LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Prophage
Oncophage
Retrocyte Display
SECANT
AutoSynVax
QS-21 Stimulon
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: